Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Halank

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
NPJ Genomic Medicine|March 26, 2025
Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertensionSofia Karl, Ekkehard Grünig, Memoona Shaukat, et al.
Journal of the American College of Cardiology|December 19, 2006
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centersMarius M Hoeper, Stephen H Lee, Robert Voswinckel, et al.
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
Pulmonary Circulation|March 25, 2020
Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
BMC Pulmonary Medicine|December 29, 2017
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access studyVallerie V McLaughlin, Pavel Jansa, Jens E Nielsen-Kudsk, et al.
Deutsche Medizinische Wochenschrift (1946)|July 6, 2019
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]Stephan Rosenkranz, Gerhard-Paul Diller, Daniel Dumitrescu, et al.
Journal of Thrombosis and Haemostasis : JTH|July 22, 2023
Circulating microRNAs predict recurrence and death following venous thromboembolismVincent Ten Cate, Steffen Rapp, Andreas Schulz, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
NPJ Genomic Medicine|March 26, 2025
Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertensionSofia Karl, Ekkehard Grünig, Memoona Shaukat, et al.
Journal of the American College of Cardiology|December 19, 2006
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centersMarius M Hoeper, Stephen H Lee, Robert Voswinckel, et al.
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
Pulmonary Circulation|March 25, 2020
Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
BMC Pulmonary Medicine|December 29, 2017
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access studyVallerie V McLaughlin, Pavel Jansa, Jens E Nielsen-Kudsk, et al.
Deutsche Medizinische Wochenschrift (1946)|July 6, 2019
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]Stephan Rosenkranz, Gerhard-Paul Diller, Daniel Dumitrescu, et al.
Journal of Thrombosis and Haemostasis : JTH|July 22, 2023
Circulating microRNAs predict recurrence and death following venous thromboembolismVincent Ten Cate, Steffen Rapp, Andreas Schulz, et al.
Pageof 14